These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1849076

  • 41. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
    Weis JJ, Richards SA, Smith JA, Fearon DT.
    J Immunol Methods; 1986 Aug 21; 92(1):79-87. PubMed ID: 3018085
    [Abstract] [Full Text] [Related]

  • 42. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M, Gauffre A, Lyamani F, Fiandino A, Hermann J, Frade R.
    J Immunol; 1991 Aug 15; 147(4):1286-91. PubMed ID: 1831222
    [Abstract] [Full Text] [Related]

  • 43. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).
    Moore MD, DiScipio RG, Cooper NR, Nemerow GR.
    J Biol Chem; 1989 Dec 05; 264(34):20576-82. PubMed ID: 2555366
    [Abstract] [Full Text] [Related]

  • 44. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT.
    Proc Natl Acad Sci U S A; 1984 Jul 05; 81(14):4510-4. PubMed ID: 6087328
    [Abstract] [Full Text] [Related]

  • 45. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ, Tedder TF, Fearon DT.
    Proc Natl Acad Sci U S A; 1984 Feb 05; 81(3):881-5. PubMed ID: 6230668
    [Abstract] [Full Text] [Related]

  • 46. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
    Clemenza L, Isenman DE.
    J Immunol; 2000 Oct 01; 165(7):3839-48. PubMed ID: 11034390
    [Abstract] [Full Text] [Related]

  • 47. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R, Rasmussen JM, Hansen HV, Bysted P, Svehag SE.
    J Clin Lab Immunol; 1988 Mar 01; 25(3):153-6. PubMed ID: 2969415
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.
    Kuraya M, Sato T, Fujita T.
    Microbiol Immunol; 1995 Mar 01; 39(2):145-51. PubMed ID: 7783687
    [Abstract] [Full Text] [Related]

  • 50. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 51. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
    Barel M, Fiandino A, Delcayre AX, Lyamani F, Frade R.
    J Immunol; 1988 Sep 01; 141(5):1590-5. PubMed ID: 2842398
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD.
    Eur J Immunol; 1992 May 01; 22(5):1123-31. PubMed ID: 1315687
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
    Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD.
    J Immunol; 1993 Jun 15; 150(12):5311-20. PubMed ID: 8390533
    [Abstract] [Full Text] [Related]

  • 58. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
    Lambris JD, Dobson NJ, Ross GD.
    Proc Natl Acad Sci U S A; 1981 Mar 15; 78(3):1828-32. PubMed ID: 6101236
    [Abstract] [Full Text] [Related]

  • 59. Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.
    Martin DR, Marlowe RL, Ahearn JM.
    J Virol; 1994 Aug 15; 68(8):4716-26. PubMed ID: 7913508
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.